Skip to main content
Shirish Gadgeel, MD, Oncology, Detroit, MI

Shirish Madhav Gadgeel MD

Oncology•Detroit, MI

Hematologic Oncology, Thoracic Cancer

Chief, Division of Hematology & Oncology, Department of Internal Medicine, Henry Ford Cancer Institute/Henry Ford Hospital

Join to view full profile

  • 2799 W Grand BlvdDetroit, MI 48202

  • Phone+1 800-653-6568

  • Fax+1 313-916-3711

Dr. Gadgeel is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Gadgeel's full profileAlready have an account?

Education & Training

  • Detroit Medical Center/Wayne State University
    Detroit Medical Center/Wayne State UniversityFellowship, Hematology and Medical Oncology, 1996 - 2000
  • Wayne State University School of Medicine
    Wayne State University School of MedicineResidency, Internal Medicine, 1994 - 1996
  • Zucker School of Medicine at Hofstra/Northwell
    Zucker School of Medicine at Hofstra/NorthwellInternship, Internal Medicine, 1993 - 1994
  • Grant Medical College
    Grant Medical CollegeClass of 1992

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2026 - 2028
  • MI State Medical License
    MI State Medical License 1995 - 2027
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Most Compassionate Doctor American Registry

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • S1507: Phase II study of docetaxel and trametinib in patients with G12C or non-G12C KRAS mutation positive (+) recurrent non-small cell lung cancer (NSCLC). 
    2019 ASCO Annual Meeting - 6/1/2019
  • Management of Immunotherapy Toxicities in Patients With Lung Cancer 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Authored Content

  • Second-Line Treatment Options in Non-Small Cell Lung Cancer (NSCLC): Report from an International Experts Panel Meeting of the Italian Association of Thoracic OncologyDecember 2017

Press Mentions

  • Life After Lung Cancer: Supporting Young Adults Through the Unique Challenges of Survivorship
    Life After Lung Cancer: Supporting Young Adults Through the Unique Challenges of SurvivorshipSeptember 29th, 2025
  • Navigating Early-Stage ALK+ Lung Cancer: Patient-Centered Strategies for Balancing Treatment and Quality of Life
    Navigating Early-Stage ALK+ Lung Cancer: Patient-Centered Strategies for Balancing Treatment and Quality of LifeSeptember 26th, 2025
  • Managing Neurocognitive Side Effects in Patients with ALK+ NSCLC: What Oncology Nurses Should Know
    Managing Neurocognitive Side Effects in Patients with ALK+ NSCLC: What Oncology Nurses Should KnowSeptember 25th, 2025

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Shirish Gadgeel, Dr. Shirish Gadgeel, MD, Dr. S Gadgeel, Dr. Shirish Madhav Gadgeel